These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1578483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR, Higginbottom M, Hill DR, Horwell DC, Hughes J, Rees DC, Roberts E, Singh L, Suman-Chauhan N, Woodruff GN.
    J Med Chem; 1993 Mar 05; 36(5):552-65. PubMed ID: 7684452
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amide bond replacements incorporated into CCK-B selective "dipeptoids".
    Fincham CI, Higginbottom M, Hill DR, Horwell DC, O'Toole JC, Ratcliffe GS, Rees DC, Roberts E.
    J Med Chem; 1992 Apr 17; 35(8):1472-84. PubMed ID: 1573640
    [Abstract] [Full Text] [Related]

  • 9. Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
    Augelli-Szafran CE, Horwell DC, Kneen C, Ortwine DF, Pritchard MC, Purchase TS, Roth BD, Trivedi BK, Hill D, Suman-Chauhan N, Webdale L.
    Bioorg Med Chem; 1996 Oct 17; 4(10):1733-45. PubMed ID: 8931944
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O, Maldonado R, Fournie-Zaluski MC, Roques BP.
    J Pharmacol Exp Ther; 1994 Jul 17; 270(1):77-88. PubMed ID: 8035345
    [Abstract] [Full Text] [Related]

  • 17. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
    Martín-Martínez M, De La Figuera N, Latorre M, Herranz R, García-López MT, Cenarruzabeitia E, Del Río J, González-Muñiz R.
    J Med Chem; 2000 Oct 05; 43(20):3770-7. PubMed ID: 11020292
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K, Lin CW, Kopecka H, Craig R, Wagenaar FL, Bianchi B, Miller T, Witte D, Nadzan AM.
    J Med Chem; 1990 Nov 05; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.